{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:50:36Z","timestamp":1788468636149,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["760928"],"award-info":[{"award-number":["760928"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.coph.2020.11.002","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T22:13:04Z","timestamp":1608243184000},"page":"85-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"special_numbering":"C","title":["Nanotechnology in pulmonary medicine"],"prefix":"10.1016","volume":"56","author":[{"given":"Mohammad","family":"Doroudian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"O\u2019 Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3164-1607","authenticated-orcid":false,"given":"Ronan","family":"Mac Loughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4371-2214","authenticated-orcid":false,"given":"Adriele","family":"Prina-Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Volkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seamas C.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2020.11.002_bib1","article-title":"Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017","volume":"368","author":"Li","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.coph.2020.11.002_bib2","series-title":"The burden of lung disease: the European Lung white book","year":"2011"},{"key":"10.1016\/j.coph.2020.11.002_bib3","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1183\/09031936.00007915","article-title":"Barriers to new drug development in respiratory disease","volume":"45","author":"Barnes","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.coph.2020.11.002_sref4","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/thoraxjnl-2019-213037","article-title":"Nanotechnology based therapeutics for lung disease","volume":"74","author":"Doroudian","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.coph.2020.11.002_bib5","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1016\/j.vaccine.2011.06.111","article-title":"Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.coph.2020.11.002_bib6","doi-asserted-by":"crossref","first-page":"1807616","DOI":"10.1002\/adfm.201807616","article-title":"Viromimetic STING agonist-loaded hollow polymeric nanoparticles for safe and effective vaccination against Middle East respiratory syndrome coronavirus","volume":"29","author":"Lin","year":"2019","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.coph.2020.11.002_bib7","doi-asserted-by":"crossref","first-page":"1901176","DOI":"10.1002\/adhm.201901176","article-title":"Double-layered m2e-NA protein nanoparticle immunization induces broad cross-protection against different influenza viruses in mice","volume":"9","author":"Wang","year":"2020","journal-title":"Advanced healthcare materials"},{"key":"10.1016\/j.coph.2020.11.002_bib8","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41565-020-0751-0","article-title":"Nanotechnology-based disinfectants and sensors for SARS-CoV-2","volume":"15","author":"Talebian","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.coph.2020.11.002_bib9","article-title":"How can nanotechnology help to combat COVID-19? Opportunities and urgent need","volume":"18","author":"Campos","year":"2020","journal-title":"J\u00a0Nanobiotechnol"},{"key":"10.1016\/j.coph.2020.11.002_sref10","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-2836(65)80093-6","article-title":"Diffusion of univalent ions across the lamellae of swollen phospholipids","volume":"13","author":"Bangham","year":"1965","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.coph.2020.11.002_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/nano10020183","article-title":"Multifunctional nanocarriers for lung drug delivery","volume":"10","author":"Pontes","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.coph.2020.11.002_bib12","doi-asserted-by":"crossref","first-page":"101502","DOI":"10.1016\/j.jddst.2020.101502","article-title":"Inhalable spray dried lipidnanoparticles for the co-delivery of paclitaxel and doxorubicin in lung cancer","volume":"56","author":"Kaur","year":"2020","journal-title":"J\u00a0Drug Deliv Sci Technol"},{"key":"10.1016\/j.coph.2020.11.002_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2019.00406","article-title":"Nanomedicine approaches for the pulmonary treatment of cystic fibrosis","volume":"7","author":"Velino","year":"2019","journal-title":"Frontiers in Bioengineering Biotechnology"},{"key":"10.1016\/j.coph.2020.11.002_bib14","series-title":"Diagnosis of tuberculosis: Nanodiagnostics approaches, in NanoBioMedicine","first-page":"261","author":"Gupta","year":"2020"},{"key":"10.1016\/j.coph.2020.11.002_bib15","doi-asserted-by":"crossref","first-page":"119958","DOI":"10.1016\/j.ijpharm.2020.119958","article-title":"Aerosolized hyaluronic acid decorated, ferulic acid loaded chitosan nanoparticle: a promising asthma control strategy","volume":"591","author":"Dhayanandamoorthy","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.coph.2020.11.002_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12951-020-00703-5","article-title":"Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review","volume":"18","author":"Xu","year":"2020","journal-title":"J\u00a0Nanobiotechnol"},{"key":"10.1016\/j.coph.2020.11.002_bib17","first-page":"e1654","article-title":"Nanomedicine in lung cancer: current states of overcoming drug resistance and improving cancer immunotherapy","author":"Wang","year":"2020","journal-title":"WIREs Nanomedicine and Nanobiotechnology"},{"key":"10.1016\/j.coph.2020.11.002_bib18","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41565-020-0737-y","article-title":"COVID-19 vaccine development and a potential nanomaterial path forward","volume":"15","author":"Shin","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.coph.2020.11.002_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00837-18","article-title":"A\u00a0novel nanobody targeting Middle East respiratory syndrome coronavirus (MERS-CoV) receptor-binding domain has potent cross-neutralizing activity and protective efficacy against MERS-CoV","volume":"92","author":"Zhao","year":"2018","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.coph.2020.11.002_bib20","doi-asserted-by":"crossref","first-page":"12125","DOI":"10.1021\/acsnano.0c05657","article-title":"Multiplexed nanomaterial-based sensor array for detection of COVID-19 in exhaled breath","volume":"14","author":"Shan","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.coph.2020.11.002_bib21","doi-asserted-by":"crossref","first-page":"142363","DOI":"10.1016\/j.scitotenv.2020.142363","article-title":"Prospects of nanomaterials-enabled biosensors for COVID-19 detection","volume":"754","author":"Srivastava","year":"2021","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.coph.2020.11.002_bib22","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s13346-020-00786-5","article-title":"Nano-based anti-tubercular drug delivery: an emerging paradigm for improved therapeutic intervention","volume":"10","author":"Nabi","year":"2020","journal-title":"Drug Delivery and Translational Research"},{"key":"10.1016\/j.coph.2020.11.002_bib23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jconrel.2020.05.022","article-title":"Recent advances in long-acting nanoformulations for delivery of antiretroviral drugs","volume":"324","author":"Surve","year":"2020","journal-title":"J\u00a0Contr Release"},{"key":"10.1016\/j.coph.2020.11.002_bib24","first-page":"2000203","article-title":"Targeted Nanotherapeutics for respiratory diseases: cancer, fibrosis, and coronavirus","author":"Majumder","year":"2020","journal-title":"Advanced Therapeutics"},{"key":"10.1016\/j.coph.2020.11.002_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tibtech.2012.12.006","article-title":"Combination approaches to combat multidrug-resistant bacteria","volume":"31","author":"Worthington","year":"2013","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.coph.2020.11.002_bib26","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.2147\/DDDT.S246574","article-title":"Combination chemotherapy of lung cancer - Co-delivery of docetaxel prodrug and Cisplatin using aptamer-decorated lipid-polymer hybrid nanoparticles","volume":"14","author":"Wu","year":"2020","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.coph.2020.11.002_bib27","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/pharmaceutics12030254","article-title":"Dual peptide-modified nanoparticles improve combination chemotherapy of Etoposide and siPIK3CA against drug-resistant small cell lung carcinoma","volume":"12","author":"Huang","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.coph.2020.11.002_bib28","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1080\/10717544.2019.1676841","article-title":"Active pulmonary targeting against tuberculosis (TB) via triple-encapsulation of Q203, bedaquiline and superparamagnetic iron oxides (SPIOs) in nanoparticle aggregates","volume":"26","author":"Poh","year":"2019","journal-title":"Drug Deliv"},{"key":"10.1016\/j.coph.2020.11.002_bib29","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1038\/s41598-017-05453-3","article-title":"Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles","volume":"7","author":"Costa-Gouveia","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2020.11.002_bib30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2019.01.025","article-title":"Inhalation treatment of cystic fibrosis with lumacaftor and ivacaftor co-delivered by nanostructured lipid carriers","volume":"296","author":"Garbuzenko","year":"2019","journal-title":"J\u00a0Contr Release"},{"key":"10.1016\/j.coph.2020.11.002_bib31","doi-asserted-by":"crossref","first-page":"100558","DOI":"10.1016\/j.apmt.2020.100558","article-title":"Bioreducible and traceable Ru(III) prodrug-loaded mesoporous silica nanoparticles for sequentially targeted nonsmall cell lung cancer chemotherapy","volume":"19","author":"Chen","year":"2020","journal-title":"Applied Materials Today"},{"key":"10.1016\/j.coph.2020.11.002_bib32","doi-asserted-by":"crossref","first-page":"7363","DOI":"10.1039\/C9TB01602C","article-title":"Bypassing pro-survival and resistance mechanisms of autophagy in EGFR-positive lung cancer cells by targeted delivery of 5FU using theranostic Ag2S quantum dots","volume":"7","author":"Duman","year":"2019","journal-title":"J\u00a0Mater Chem B"},{"key":"10.1016\/j.coph.2020.11.002_sref33","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.7150\/thno.38069","article-title":"Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics","volume":"10","author":"Mi","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.coph.2020.11.002_sref34","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.7150\/thno.17573","article-title":"Lung cancer-targeting peptides with multi-subtype indication for combinational drug delivery and molecular imaging","volume":"7","author":"Chi","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.coph.2020.11.002_bib35","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2147\/IJN.S226186","article-title":"Subcellular performance of nanoparticles in cancer therapy","volume":"15","author":"Liu","year":"2020","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.coph.2020.11.002_bib36","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3390\/pharmaceutics11100543","article-title":"Active cellular and subcellular targeting of nanoparticles for drug delivery","volume":"11","author":"Nag","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.coph.2020.11.002_bib37","article-title":"Nanoparticle delivery systems with cell-specific targeting for pulmonary diseases","author":"Deng","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.coph.2020.11.002_bib38","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41467-018-02915-8","article-title":"Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance","volume":"9","author":"Wang","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coph.2020.11.002_bib39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12951-019-0562-3","article-title":"Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis","volume":"18","author":"Wang","year":"2020","journal-title":"J\u00a0Nanobiotechnol"},{"key":"10.1016\/j.coph.2020.11.002_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-49514-1","article-title":"Differentiating lung cancer and infection based on measurements of extracellular pH with acidoCEST MRI","volume":"9","author":"Lindeman","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2020.11.002_bib41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1172\/JCI34431","article-title":"A\u00a0calculated response: control of inflammation by the innate immune system","volume":"118","author":"Barton","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.coph.2020.11.002_bib42","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/10717544.2019.1709922","article-title":"Layer-by-layer pH-sensitive nanoparticles for drug delivery and controlled release with improved therapeutic efficacy in\u00a0vivo","volume":"27","author":"Men","year":"2020","journal-title":"Drug Deliv"},{"key":"10.1016\/j.coph.2020.11.002_bib43","doi-asserted-by":"crossref","first-page":"16380","DOI":"10.1021\/acsami.9b04051","article-title":"pH-responsive nanoparticles targeted to lungs for improved therapy of acute lung inflammation\/injury","volume":"11","author":"Zhang","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.coph.2020.11.002_bib44","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1039\/C9TB02764E","article-title":"Stimuli-responsive release and efficient siRNA delivery in non-small cell lung cancer by a poly(l-histidine)-based multifunctional nanoplatform","volume":"8","author":"Shi","year":"2020","journal-title":"J\u00a0Mater Chem B"},{"key":"10.1016\/j.coph.2020.11.002_bib45","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1039\/C8CC09432B","article-title":"Dual stimuli-responsive bispillar[5]arene-based nanoparticles for precisely selective drug delivery in cancer cells","volume":"55","author":"Cheng","year":"2019","journal-title":"Chem Commun"},{"key":"10.1016\/j.coph.2020.11.002_bib46","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1039\/C9TB02055A","article-title":"Programmed co-delivery of platinum nanodrugs and gemcitabine by a clustered nanocarrier for precision chemotherapy for NSCLC tumors","volume":"8","author":"Shi","year":"2020","journal-title":"J\u00a0Mater Chem B"},{"key":"10.1016\/j.coph.2020.11.002_bib47","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1021\/acs.accounts.7b00047","article-title":"Innovative nanosensor for disease diagnosis","volume":"50","author":"Kim","year":"2017","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.coph.2020.11.002_bib48","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41565-020-0723-4","article-title":"Engineering synthetic breath biomarkers for respiratory disease","volume":"15","author":"Chan","year":"2020","journal-title":"Nat Nanotechnol"},{"key":"10.1016\/j.coph.2020.11.002_bib49","article-title":"Applications and strategies in nanodiagnosis and nanotherapy in lung cancer","author":"Woodman","year":"2020","journal-title":"Semin Canc Biol"},{"key":"10.1016\/j.coph.2020.11.002_bib50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bios.2019.01.011","article-title":"Nanoscale fluorescent metal\u2013organic framework composites as a logic platform for potential diagnosis of asthma","volume":"130","author":"Zhang","year":"2019","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/j.coph.2020.11.002_bib51","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ebiom.2018.11.031","article-title":"Protease activity sensors noninvasively classify bacterial infections and antibiotic responses","volume":"38","author":"Buss","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coph.2020.11.002_bib52","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.0c02439","article-title":"Dual-functional plasmonic photothermal biosensors for highly accurate severe acute respiratory syndrome coronavirus 2 detection","author":"Qiu","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.coph.2020.11.002_sref53","series-title":"Reverse transcription loop-mediated isothermal amplification combined with nanoparticles-based biosensor for diagnosis of COVID-19","first-page":"2020","author":"Zhu","year":"2020"},{"key":"10.1016\/j.coph.2020.11.002_bib54","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.1021\/acsnano.0c02823","article-title":"Rapid detection of COVID-19 causative virus (SARS-CoV-2) in human nasopharyngeal swab specimens using field-effect transistor-based biosensor","volume":"14","author":"Seo","year":"2020","journal-title":"ACS Nano"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489220301296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489220301296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:52:36Z","timestamp":1761461556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489220301296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":54,"alternative-id":["S1471489220301296"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2020.11.002","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanotechnology in pulmonary medicine","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2020.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}